TCB-2

From WikiMD's Wellnesspedia

TCB-2 is a psychedelic drug that was first synthesized by Alexander Shulgin. It is a potent and selective partial agonist for the serotonin 5-HT2A receptor, and is thought to be a research chemical that has been sold online as a designer drug.

Chemistry[edit | edit source]

TCB-2 is a member of the 25-NB family. It is structurally related to 2C-B and DOB, with the 4-bromo group of 2C-B replaced by a 4-chloro group, and the 2,5-dimethoxy groups of DOB replaced by 2,5-dichloro groups.

Pharmacology[edit | edit source]

TCB-2 is a partial agonist at the 5-HT2A receptor. It has a high affinity for this receptor, with a Ki of 0.25 nM. This makes it around 6 times more potent than DOB, and slightly less potent than LSD.

Effects[edit | edit source]

The effects of TCB-2 are not well documented, as it is a relatively new substance. However, it is thought to produce effects similar to other psychedelic drugs, such as visual hallucinations, altered perception, and euphoria.

Legal Status[edit | edit source]

In the United States, TCB-2 is not specifically listed as a controlled substance, but it may be considered an analog of 2C-B or DOB, which are Schedule I drugs under the Controlled Substances Act.

See Also[edit | edit source]

References[edit | edit source]


TCB-2 Resources

Find a healthcare provider anywhere in the world quickly and easily!

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD